Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
Study on Metreleptin for Patients with Partial Lipodystrophy
BelgiumLong-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
BelgiumStudy of LY3473329 for Adults with High Lipoprotein(a) Levels at Risk for Heart Problems
GermanyStudy on Eptinezumab for Painful Diabetic Neuropathy in Adults
DenmarkStudy on Dasatinib and Quercetin for Patients with Osteoporosis or Osteopenia
DenmarkStudy on Glucagon and Insulin for Improving Insulin Absorption in Patients with Type 1 Diabetes
NorwayStudy on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides
BelgiumStudy on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy
AustriaStudy on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight
AustriaStudy on the Effects of Empagliflozin on Blood Sugar Levels in Patients with HNF1A-MODY Diabetes
DenmarkStudy on Patiromer and Placebo for Managing Hyperkalemia in Non-Dialysis Patients with Chronic Kidney Disease Stages IIIB to V
ItalyStudy on the Effects of Modified-Release Hydrocortisone vs. Immediate-Release Hydrocortisone for Patients with Addison's Disease
IrelandThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
